Acutaas Chemicals Stock Screener | Share Price & Fundamental Analysis
ACUTAAS
Pharmaceuticals
Share Price NSE
₹2335.90
▲
121.90 (5.51%)
Share Price BSE
₹2341.10
▲
132.20 (5.98%)
Track Acutaas Chemicals share price live with TickJournal's free stock screener.
Analyze Acutaas Chemicals share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Acutaas Chemicals Market Cap
₹17,276.44 Cr.
ACUTAAS P/E Ratio (TTM)
66.89
Acutaas Chemicals P/B Ratio
13.48
EPS (TTM)
₹19.91
Dividend Yield
0.06%
Debt to Equity
0.12
ACUTAAS 52 Week High
₹2558.60
Acutaas Chemicals 52 Week Low
₹1069.80
Operating Margin
28.00%
Profit Margin
20.06%
ACUTAAS Revenue (TTM)
₹314.00
EBITDA
₹91.00
Net Income
₹63.00
Total Assets
₹1,549.00
Total Equity
₹1,320.00
Acutaas Chemicals Share Price History - Stock Screener Chart
Screen ACUTAAS historical share price movements with interactive charts. Analyze price trends and patterns.
Acutaas Chemicals Company Profile - Fundamental Screener
Screen Acutaas Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ACUTAAS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE00FF01025
Acutaas Chemicals Balance Sheet Screener
Screen ACUTAAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Assets | 792 | 493 | 457 | 430 | 216 | 121 | 124 |
| Fixed Assets | 570 | 427 | 259 | 205 | 186 | 85 | 79 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 27 | 128 | 10 | 7 | 80 | 26 | 25 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 1,320 | 683 | 594 | 522 | 167 | 112 | 82 |
| Share Capital | 41 | 37 | 36 | 36 | 32 | 11 | 11 |
| Reserves & Surplus | 1,269 | 637 | 558 | 486 | 135 | 101 | 72 |
Acutaas Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Acutaas Chemicals income statement and profit fundamentals.
Analyze ACUTAAS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Acutaas Chemicals share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 314 | 223 | 316 | 398 | 226 | 178 | 255 | 277 | 186 | 155 | 174 | 170 | 144 | 132 | 148 |
| Expenses | 224 | 156 | 211 | 243 | 182 | 147 | 198 | 206 | 146 | 120 | 179 | 140 | 118 | 108 | 119 |
| EBITDA | 91 | 67 | 105 | 155 | 44 | 31 | 57 | 70 | 41 | 35 | -5 | 30 | 26 | 24 | 29 |
| Operating Profit % | 28.00% | 25.00% | 31.00% | 38.00% | 19.00% | 17.00% | 20.00% | 25.00% | 22.00% | 22.00% | -4.00% | 16.00% | 18.00% | 18.00% | 19.00% |
| Depreciation | 7 | 8 | 8 | 10 | 5 | 6 | 7 | 6 | 3 | 4 | 4 | 4 | 3 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 0 | 0 |
| Profit Before Tax | 83 | 58 | 96 | 145 | 37 | 20 | 50 | 63 | 37 | 31 | -10 | 24 | 22 | 20 | 26 |
| Tax | 20 | 14 | 24 | 38 | 12 | 5 | 13 | 18 | 10 | 9 | 7 | 6 | 1 | 6 | 7 |
| Net Profit | 63 | 44 | 72 | 106 | 26 | 15 | 38 | 46 | 27 | 22 | -17 | 18 | 21 | 15 | 19 |
| EPS | 7.80 | 5.41 | 8.82 | 13.19 | 6.85 | 3.67 | 9.38 | 11.35 | 7.47 | 4.57 | -4.67 | 4.83 | 6.22 | 4.08 | 5.50 |
Acutaas Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen ACUTAAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 118 | 125 | 66 | -12 | 28 | 27 | 15 | 9 | 29 | 10 |
| Investing Activities | -224 | -365 | -33 | -121 | -101 | -24 | -21 | -25 | -19 | -14 |
| Financing Activities | 261 | 239 | -12 | 140 | 72 | 0 | 6 | 15 | -7 | 4 |
| Net Cash Flow | 156 | -1 | 20 | 8 | -1 | 3 | 0 | -2 | 3 | 0 |
Acutaas Chemicals Shareholding Pattern Screener
See Acutaas Chemicals shareholding pattern with promoter, FII, and DII holdings.
Check Acutaas Chemicals promoter holding and ownership changes for ACUTAAS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-May | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.96% | 32.66% | 32.66% | 32.66% | 39.91% | 39.07% | 35.98% | 35.97% |
| FII Holding | 16.48% | 16.94% | 16.85% | 16.67% | 8.97% | 10.01% | 12.92% | 13.87% |
| DII Holding | 18.31% | 22.38% | 22.59% | 21.70% | 6.81% | 8.81% | 14.81% | 19.93% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.19% | 23.27% | 22.79% | 23.53% | 30.01% | 28.79% | 26.06% | 24.72% |
| Other Holding | 5.05% | 4.74% | 5.10% | 5.43% | 14.30% | 13.33% | 10.22% | 5.51% |
| Shareholder Count | 114,060 | 119,890 | 108,664 | 110,363 | 95,784 | 92,721 | 90,329 | 93,394 |
Acutaas Chemicals Share Dividend Screener - Share Yield Analysis
Check Acutaas Chemicals dividend history with payout and yield data.
View Acutaas Chemicals dividend details including ex-dates and amounts for ACUTAAS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 0.06% |
| 2024-March | ₹3.00 | 0.25% |
| 2023-March | ₹3.00 | 0.55% |
| 2022-March | ₹3.00 | 0.67% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Acutaas Chemicals Stock Index Membership
See which indices include Acutaas Chemicals stock.
Check ACUTAAS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Acutaas Chemicals Market Events Screener - Corporate Actions
Get Acutaas Chemicals corporate actions including splits, bonuses, and buybacks.
Check Acutaas Chemicals stock events that may affect ACUTAAS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 10.98% | ||
| Dividend | ₹ 3.00 /share | 22.46% | ||
| Dividend | ₹ 3.00 /share | 22.48% | ||
| Dividend | ₹ 1.50 /share | 30.24% | ||
| Annual General Meeting | NA | 2.58% | ||
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | 6.40% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 9.19% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.68% |
| 2025-05-10 | 2025-05-10 | Extraordinary General Meeting | NA | -1.46% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 2.70% |
| 2025-04-25 | 2025-02-22 | Split | 5:10 | 0.00% |
| 2025-04-16 | 2025-04-16 | Change Of Name | NA | 0.00% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -3.56% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 9.42% |
| 2022-07-29 | 2022-08-01 | Dividend | ₹ 3.00 /share | 10.65% |
Acutaas Chemicals Competitors Screener - Peer Comparison
Screen ACUTAAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Acutaas Chemicals Company Announcements - News Screener
Screen ACUTAAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-11 | Update On Acquisition | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-30 | General Update | - |
| 2026-01-29 | Annual Sustainability Report Of The Company For The Financial Year 2024-25 | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-28 | Earnings Call Recording Pursuant To SEBI (LODR) Regulations 2015 | - |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-28 | Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On January 28 2026 | - |
| 2026-01-27 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-21 | Board Meeting Intimation for The Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 To Be Held On January 28 2026 | - |
| 2026-01-19 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |